1Schummer M, Ng WV et al.'Comparative hybridization of an ar- ray of 21,500 ovarian cDNAs for the discovery of genes overex- pressed in ovarian carcirmmaa[J]. Gene, 2009,248 (2) : 375-385.
2Kirchhoff C, I-labben I, Ivetl R, et al. A major human epididymis- specific cDNA encodes a protein with sequence homology to extra- cellular proteinase inhihitors[J]. Biol .Reprod, 2008,54 (2) : 350- 357.
3Kirchhoff C. Molecular characterization of epididymal proteins [J]. Rev Reprod,2008,13(1) :86-95.
4Ranganathan S,Simpson KJ,Shaw DC,et al. The whey acidic pro- tein family:a new signature motif and three-dimensional structure by comparative modeling [J]. J Mol Graph Model, 1999,17 ( 2 ) : 106-113,134-136.
5Galgano MT, Hampton GM, Frierson HF. Comprehensive analysisof HE4 expression in normal and malignant human tissues[J]. Modern Path,2006,19(7) :847-853.
6Gao L,Cheng HY,Dong L,et al. The role of HE4 in ovarian canc- er:inhibiting tumor cell proliferation and metastasis[J]. J Int Med Res, 2011,39 (5) : 1645-1660.
7Jemal A,Clegg LX,Ward E,et al. Annual report to the nation on the status of cancer, 1975--2001, with a special feature regarding survival[J]. Cancer, 2008,104 (2) : 322-327.
8Chang X,Ye X,Dong L,et al. Human epididymis protein 4(HE4) as a serum tumor biomarker in patients with ovarian carcinoma [J]. Inter J Gynecol Cancer,2011,21(7) :852-858.
9Lin J, Qin J, Sangvatanakul V. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and o- varian cancer: a systematic review and meta-analysis[J]. Eur J Obstet Gyneeol Reprod Biol, 2013,167 (1) : 81-85.
2Moore RG,Brown AK,Miller MC,et al.The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.Cynecol Oncol,2008,108:402-408.
3Havrilesky LJ,Whitehead CM,Rubatt JM,et al.Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.Gynecol Oncol,2008,110:374-382.
4Drapkin R,von Horsten HH,Lin Y,et al.Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.Cancer Res,2005,65:2162-2169.
5Galgano MT,Hampton GM,Frierson HF Jr.Comprehensive analysis of HE4 expression in normal and malignant human tissues.Mod Pathol,2006,19:847-853.
6Moore RG,Brown AK,Miller MC,et al.Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.Gynecol Oncol,2008,110:196-201.
7Cagnon A,Ye B.Discovery and application of protein biomarkers for ovarian cancer.Curr Opin Obstet Gynecol,2008,20:9-13.
1Sasa K, Aleksandar S, Katarina J, et al. The utility of human epi- didymal protein 4 ,cancer antigen 125, and risk for malignancy al- gorithm in ovarian cancer and endometriosis [ J ]. Int J Gynecol Cancer, 2012,22 ( 2 ) : 238 -244.
2Bast Jr Rc, Feeney M, Lazarus H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma[ J]. J Clin Invest, 1981,68 (5) :1331-1337.
3Kirchhoff C , Habben I, Ivell R, et al. A major human epididymis- specific cDNA encodes a protein with sequence homology to extra- cellular proteinase inhibitors [ J ]. Biol Reprod, 1991,45 ( 2 ) :350- 357.
4Moore RG,Memeekin DS,Brown AK,et al. A novel multiple mark- er bioassay utilizing HE4 and CA125 for the prediction of ovarian Cancer in patients with a pelvic mass [ J 1. Gyneeol Oncol, 2009, 112( 1 ) :40-46.
5Li J,Dowdy S,Tipton T,et al. HE4 as a biomarker for ovarian and endometrial cancer management [ J ]. Expert Rev Mol Diagn, 2009,9(6) :555-566.
